Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Two-year virologic outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in Uganda.

Chang LW, Alamo S, Guma S, Christopher J, Suntoke T, Omasete R, Montis JP, Quinn TC, Juncker M, Reynolds SJ.

J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):276-82. doi: 10.1097/QAI.0b013e3181988375.

2.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
3.

Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.

Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):37-46. doi: 10.1097/QAI.0b013e31819ff102.

4.

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.

Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, Wit FW, Waalberg E, Rinke de Wit TF, Lange JM; Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):262-7.

PMID:
17146376
5.

Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.

Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC.

Clin Infect Dis. 2006 Jan 15;42(2):252-9. Epub 2005 Dec 12.

PMID:
16355337
6.

Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort.

Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, Rubaale T, Senthilselvan A, Okech-Ojony J.

PLoS One. 2012;7(7):e40902. doi: 10.1371/journal.pone.0040902. Epub 2012 Jul 17.

7.

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G.

Ann Intern Med. 2007 Apr 17;146(8):564-73.

PMID:
17438315
8.

Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda.

Reynolds SJ, Nakigozi G, Newell K, Ndyanabo A, Galiwongo R, Boaz I, Quinn TC, Gray R, Wawer M, Serwadda D.

AIDS. 2009 Mar 27;23(6):697-700. doi: 10.1097/QAD.0b013e3283262a78.

9.

Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses.

Kabugo C, Bahendeka S, Mwebaze R, Malamba S, Katuntu D, Downing R, Mermin J, Weidle PJ.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):578-83.

PMID:
15793369
10.

Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.

Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G.

AIDS. 2008 Oct 18;22(16):2117-25. doi: 10.1097/QAD.0b013e328310407e.

11.

Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial.

Chang LW, Kagaayi J, Nakigozi G, Ssempijja V, Packer AH, Serwadda D, Quinn TC, Gray RH, Bollinger RC, Reynolds SJ.

PLoS One. 2010 Jun 2;5(6):e10923. doi: 10.1371/journal.pone.0010923.

12.

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.

Djomand G, Roels T, Ellerbrock T, Hanson D, Diomande F, Monga B, Maurice C, Nkengasong J, Konan-Koko R, Kadio A, Wiktor S, Lackritz E, Saba J, Chorba T.

AIDS. 2003 Jul;17 Suppl 3:S5-15.

PMID:
14565604
13.

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB.

PLoS Med. 2008 May 20;5(5):e109. doi: 10.1371/journal.pmed.0050109.

14.

Virologic, immunologic and clinical response of infants to antiretroviral therapy in Kampala, Uganda.

Tukei VJ, Murungi M, Asiimwe AR, Migisha D, Maganda A, Bakeera-Kitaka S, Kalyesubula I, Musoke P, Kekitiinwa A.

BMC Pediatr. 2013 Mar 27;13:42. doi: 10.1186/1471-2431-13-42.

15.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
16.

Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.

Rewari BB, Bachani D, Rajasekaran S, Deshpande A, Chan PL, Srikantiah P.

J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):610-4. doi: 10.1097/QAI.0b013e3181f43a31.

PMID:
20890211
17.

Noninferiority of a task-shifting HIV care and treatment model using peer counselors and nurses among Ugandan women initiated on ART: evidence from a randomized trial.

Kiweewa FM, Wabwire D, Nakibuuka J, Mubiru M, Bagenda D, Musoke P, Fowler MG, Antelman G.

J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):e125-32. doi: 10.1097/QAI.0b013e3182987ce6.

PMID:
23807157
18.

Virologic and immunologic effectiveness of darunavir-based salvage therapy in HIV-1-infected adults in a Brazilian clinical practice setting: results of a multicenter and retrospective cohort study.

Ribeiro KM, Biscione FM, Westin MR, Machado DP, Greco DB, Tupinambás U.

Braz J Infect Dis. 2014 Jan-Feb;18(1):1-7. doi: 10.1016/j.bjid.2013.04.001. Epub 2013 Jul 31.

19.
20.

[Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru].

Alave J, Paz J, González E, Campos M, Rodríguez M, Willig J, Echevarría J.

Rev Chilena Infectol. 2013 Feb;30(1):42-8. doi: 10.4067/S0716-10182013000100006. Spanish.

Supplemental Content

Support Center